Patents Assigned to IndagoMed. LLC
  • Patent number: 10850246
    Abstract: The invention provides a new method for preparing ultra-small polymeric-lipidic delivery nanoparticles (USDNs) that were synthesized by a nanoprecipitation method followed by a layer-by-layer nanodeposition. The USDNs particle size can be controlled between 5-25 nm and provides loading capacities of 22.12% to 72.08%. Moreover, the USDNs platform provides pH controlled drug release, within a terminal release ratio of 68% at pH 5.0 and almost no release to pH of 7.5. Furthermore, based on their small sizes (5-25 nm) and unique composition, the USDNs penetrates the skin strata efficiently, release the payload at the target site as topical or transdermal treatment of a variety of skin disorders. Additionally the USDNs system can be used to treat and diagnoses other crucial diseases (Cancer, Alzheimer, etc) can be combined with various micro-needles or needles free array technologies for special application.
    Type: Grant
    Filed: November 21, 2016
    Date of Patent: December 1, 2020
    Assignee: IndagoMed, LLC
    Inventor: Anamaria Orza
  • Publication number: 20170182472
    Abstract: The invention provides a new method for preparing ultra-small polymeric-lipidic delivery nanoparticles (USDNs) that were synthesized by a nanoprecipitation method followed by a layer-by-layer nanodeposition. The USDNs particle size can be controlled between 5-25 mn and provides loading capacities of 22.12% to 72.08%. Moreover, the USDNs platform provides pH controlled drug release, within a terminal release ratio of 68% at pH 5.0 and almost no release to pH of 7.5. Furthermore, based on their small sizes (5-25 nm) and unique composition, the USDNs penetrates the skin strata efficiently, release the payload at the target site as topical or transdermal treatment of a variety of skin disorders. Additionally the USDNs system can be used to treat and diagnoses other crucial diseases (Cancer, Alzheimer, etc) can be combined with various micro-needles or needles free array technologies for special application.
    Type: Application
    Filed: November 21, 2016
    Publication date: June 29, 2017
    Applicant: IndagoMed. LLC
    Inventors: Lucian Mocan, Supha Xayprasith-Mays, Anamaria Orza
  • Publication number: 20170157005
    Abstract: The invention relates to new anti-wrinkle and anti-aging nanoformulations, composed of non-toxic mesoporous silica nanoparticles, natural plant extracts (as the case may be: pomegranate oil, fennel oil, rosemary oil, chamomile oil, jojoba oil, rosehip oil), biological active agents (acetyl hexapeptide-8, aspartic acid), vitamins and others. Additionally, the present invention relates a new method for preparing the nanoformulations by co-encapsulating its active agents within a multilayer nanocarrier, thereby, enhancing their delivery through the skin barrier and their controlled accumulation at the desired site. In certain embodiments, the active molecules are co-incorporated into an inner polymeric shell (silica derivatives) and onto its surface, followed by, the protection of an outer layer of chitosan-TAT (GRKKRRQRRRPQ). The active ingredients are crossed through the skin barrier using the disclosed delivery system to promote cell growth, skin rejuvenation and wrinkle removal.
    Type: Application
    Filed: October 26, 2016
    Publication date: June 8, 2017
    Applicant: IndagoMed. LLC
    Inventor: Anamaria Ioana Orza